logo
Ali Noorani will replace Jim Canales as Barr Foundation president

Ali Noorani will replace Jim Canales as Barr Foundation president

Boston Globe16 hours ago
'I am deeply humbled and grateful for the opportunity to lead the Barr Foundation at this moment and to build on its exceptional reputation as an institution that boldly stands in its values of deep and authentic partnership and investment in community,' he said in a Wednesday statement.
His appointment marks
a major transition
at Barr. Its current president Jim Canales will step down after an 11-year tenure, during which he expanded the foundation dramatically and
Advertisement
In a statement, Hostetter praised Noorani for his 'humility, curiosity, and the long-term view that investing in potential and empowering people in communities always requires.'
'Throughout the search, Ali's enthusiasm for Barr's core issues of arts, climate, and education was palpable, as was his readiness to propel Barr into its next chapter,' she continued.
Advertisement
Founded in 1997, Barr has invested $1.7 billion to charitable causes in arts, education, climate resiliency, and racial justice. Under Canales, the foundation grew its grantmaking from $55 million to $130 million a year and more than doubled the size of its staff, now around 50 people. (Barr also supports the Globe's
In a
On Wednesday, he touted Noorani's 'instinctual strategic acumen and personal warmth that make him a tremendous asset as Barr seeks to meet the needs of this moment and beyond.'
Jim Canales, the longtime president of the Barr foundation, will step down and transition to chair of the board by the end of the year.
Matt Kalinowski
Nonprofits across the state have taken an outsized role in upholding the state's social safety net this year, as federal programs intended to protect the vulnerable have been rolled back by the White House. The Boston Foundation
With his background in immigration, Noorani may be uniquely equipped to handle the moment, supporters said in a statement.
Advertisement
'In a time of extraordinary turbulence and disquiet, I can think of no better leader to take the helm of the Barr Foundation than Ali Noorani,' said Sam Gill, president of the New York-based Doris Duke Foundation. 'Ali's passion, intelligence, experience and humanity make him the perfect steward for the next chapter in Barr's legacy of investing in the human, natural and creative potential of our communities and our American society.'
Diti Kohli can be reached at
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Vireo Growth Inc (VREOF) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions
Vireo Growth Inc (VREOF) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions

Yahoo

time7 minutes ago

  • Yahoo

Vireo Growth Inc (VREOF) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions

Pro Forma Revenue: $90.7 million. Adjusted EBITDA: $23.2 million, with a margin of approximately 25%. Second Quarter GAAP Revenue: $48.1 million, a 91.4% increase year over year. Gross Margin: 51.6%, a reduction of 260 basis points compared to the prior year quarter. SG&A Expenses: $12.2 million, 25.4% of sales, an improvement of 480 basis points compared to Q2 last year. Adjusted Operating Income: $11.3 million, 23.5% of sales. Cash on Hand: $106.2 million at the end of Q2. Total Current Assets: $186.2 million, excluding New York assets held for sale and income taxes receivable. Total Current Liabilities: $51.8 million, excluding New York liabilities held for sale and refinanced debt. Corporate SG&A Costs: $1.8 million, a reduction of approximately 40% from the prior year quarter. Shares Outstanding: 158,617,377 shares on the Treasury method basis. Warning! GuruFocus has detected 9 Warning Signs with VREOF. Release Date: August 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Vireo Growth Inc (VREOF) reported a significant increase in GAAP revenue, up 91.4% year over year, driven by contributions from recent merger transactions. The company successfully closed three merger transactions, expanding its operational portfolio to six states and improving profitability and cash generation. Vireo Growth Inc (VREOF) completed a $153 million refinancing event, reducing annual interest expenses by approximately $10 million and increasing cash on hand to over $100 million. The company achieved an adjusted EBITDA margin of approximately 25%, with adjusted EBITDA of $23.2 million. SG&A expenses, excluding severance, improved by 480 basis points compared to the previous year, indicating better cost management. Negative Points GAAP gross margin was negatively impacted by termination fees related to a prior agreement, resulting in a reduction of 260 basis points compared to the prior year quarter. The company's performance in Minnesota was softer, affecting overall gross margin. Vireo Growth Inc (VREOF) faces uncertainty regarding the timing of adult-use cannabis sales in Minnesota, which could impact future revenue. The company is still awaiting regulatory approval for the divestment of New York assets, which could delay strategic plans. Price deflation and competition from hemp in markets like Nevada and Missouri pose challenges to maintaining market share and profitability. Q & A Highlights Q: Can you discuss the impact of the licensing agreement with Curio on your New York assets and distribution network? A: John Mazarakis, CEO & Co-Executive Chairman: The partnership with Curio does not affect the divestiture of our New York assets. Curio is a leading brand in the nutraceutical space, and we see no cannibalization with our current SKUs. We are optimistic about this relationship. Q: With the recent refinancing, what are your capital management priorities, and are there any M&A opportunities on the horizon? A: John Mazarakis, CEO & Co-Executive Chairman: We are engaging in M&A discussions, focusing on both distressed and mature spaces. While we are hopeful for M&A in the next 12 to 24 months, our primary focus remains on organic growth and achieving positive free cash flow at the unit level. Q: Can you provide an update on the Arches platform and its potential impact on growth? A: John Mazarakis, CEO & Co-Executive Chairman: We are working on deploying the Arches delivery platform. Delivery is available in all states where it is permitted, and we continue to invest in this service as we believe in its potential. Q: What preparations are being made for recreational cannabis sales in Minnesota, and how do you foresee the rollout? A: John Mazarakis, CEO & Co-Executive Chairman: We anticipate a shortage of supply in Minnesota, with initial supply coming from us and GTI. We are working with the state to ensure readiness and expect to begin adult-use sales in the second half of this year. Our retail footprint remains limited to eight locations. Q: Can you clarify the situation with your New York assets and potential partnerships there? A: John Mazarakis, CEO & Co-Executive Chairman: We are committed to a buyer for our New York assets, pending regulatory approval. Our partners have a wide network, and we aim to become the largest supplier of indoor flower in New York, leveraging this partnership. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

Will New York's Governor Endorse Mamdani for Mayor?
Will New York's Governor Endorse Mamdani for Mayor?

New York Times

time10 minutes ago

  • New York Times

Will New York's Governor Endorse Mamdani for Mayor?

Gov. Kathy Hochul might ordinarily relish the king-making power that she wields in New York as its most powerful Democrat. But in the New York City mayor's race, Ms. Hochul pointedly avoided making an endorsement in the Democratic primary and still has not backed its winner, Assemblyman Zohran Mamdani. 'I'm having very interesting conversations right now,' Ms. Hochul deflected earlier this month when asked again whom she might support, adding, 'There's no urgency.' The governor is not alone in her hesitancy. Prominent Democrats from New York — including the Senate minority leader, Chuck Schumer; Senator Kirsten Gillibrand; and the House minority leader, Hakeem Jeffries — have not made an endorsement in the race. Of the 10 House Democrats in New York City, only four have endorsed Mr. Mamdani. Like House Democrats, Ms. Hochul is facing re-election next year, potentially against Representative Elise Stefanik, a top Republican supporter of President Trump. Some political observers think that an enthusiastic endorsement of Mr. Mamdani could hurt the governor in more conservative areas of the state. 'We still have many differences, I don't know how you whitewash that away,' Ms. Hochul said in an interview on Fox News over the weekend. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store